Page 1

9/19/24 , 2:40 PM Achilles Therapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights | Achilles Therapeutics plc ACHILLES THERAPEUTICS PRESS RELEASE Achilles Therapeutics Reports Third Quarter 2021 Financial Results and Recent Business Highlights Nov 9 2021 - Oral Presentation at European Society for Gene and Cell Therapy ( ESGCT ) demonstrated ability to generate potent anti - cancer cell therapy candidates in multiple solid tumor types - - Society for Immunotherapy of Cancer ( SITC ) abstracts highlight the ability to detect , quantify and track patient - specific cNeT and generate increased cNet doses from VELOSTM Process 2 manufacturing - - Conference call and webcast scheduled for Friday , November 12 , 2021 at 8:30 am ET to review SITC presentations and provide a corporate update - LONDON , Nov. 09 , 2021 ( GLOBE NEWSWIRE ) -- Achilles Therapeutics plc ( NASDAQ : ACHL ) , a clinical - stage biopharmaceutical company developing precision T cell therapies to treat solid tumors , today announced its financial results for the third quarter ended September 30 , 2021 , and recent business highlights . https://ir.achillestx.com/news-releases/news-release-details/achilles-therapeutics-reports-third-quarter-2021-financial 1/7